Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros












Intervalo de año de publicación
2.
An Bras Dermatol ; 92(3): 404-406, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29186260

RESUMEN

Acute generalized exanthematous pustulosis is a rare drug-induced eruption that is characterized by acute, nonfollicular sterile pustules on an erythematous and edematous base. The most frequently implicated drugs are beta-lactam antibiotics. Hydroxychloroquine has been widely used to treat dermatologic and rheumatologic diseases and has been reported as a rare cause of acute generalized exanthematous pustulosis. A 42-year-old female presented with pustular lesions on the skin surface with erythema, facial edema, and occasional atypical target-like lesions after 21 days of treatment with 200mg/day hydroxychloroquine for rheumatoid arthritis, diagnosed one month previously. We report a case with acute generalized exanthematous pustulosis induced by hydroxychloroquine and treated with dapsone and systemic corticosteroid.


Asunto(s)
Pustulosis Exantematosa Generalizada Aguda/etiología , Antirreumáticos/efectos adversos , Hidroxicloroquina/efectos adversos , Pustulosis Exantematosa Generalizada Aguda/diagnóstico , Adulto , Antirreumáticos/uso terapéutico , Artritis Reumatoide/tratamiento farmacológico , Femenino , Humanos , Hidroxicloroquina/uso terapéutico
3.
An. bras. dermatol ; 92(3): 404-406, May-June 2017. graf
Artículo en Inglés | LILACS | ID: biblio-886970

RESUMEN

Abstract Acute generalized exanthematous pustulosis is a rare drug-induced eruption that is characterized by acute, nonfollicular sterile pustules on an erythematous and edematous base. The most frequently implicated drugs are beta-lactam antibiotics. Hydroxychloroquine has been widely used to treat dermatologic and rheumatologic diseases and has been reported as a rare cause of acute generalized exanthematous pustulosis. A 42-year-old female presented with pustular lesions on the skin surface with erythema, facial edema, and occasional atypical target-like lesions after 21 days of treatment with 200mg/day hydroxychloroquine for rheumatoid arthritis, diagnosed one month previously. We report a case with acute generalized exanthematous pustulosis induced by hydroxychloroquine and treated with dapsone and systemic corticosteroid.


Asunto(s)
Humanos , Femenino , Adulto , Antirreumáticos/efectos adversos , Pustulosis Exantematosa Generalizada Aguda/etiología , Hidroxicloroquina/efectos adversos , Artritis Reumatoide/tratamiento farmacológico , Antirreumáticos/uso terapéutico , Pustulosis Exantematosa Generalizada Aguda/diagnóstico , Hidroxicloroquina/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...